ERBB2 and breast cancer: In ER-positive, HER2-negative breast cancers, the maximum standardized uptake value (SUV) of 18F-fluorodeoxyglucose is associated with poor prognostic factors, including progesterone receptor status17, histologic grade, Ki-67 expression18, and 21-gene recurrence score17.